| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 11/02/2006 | CA2605453A1 Novel benzimidazole compounds having crf antagonistic activity and pharmaceutical compositions containing them |
| 11/02/2006 | CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 11/01/2006 | CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 11/01/2006 | CN1856313A Therapeutic compounds |
| 11/01/2006 | CN1856304A Derivatives of N-(1H-indazolyl)- and N-(1H-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (VR1) for the treatment of pain |
| 11/01/2006 | CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/31/2006 | US7129258 Substituted benzoxazoles as estrogenic agents |
| 10/31/2006 | US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor |
| 10/26/2006 | WO2006111517A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 10/26/2006 | WO2006111516A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 10/26/2006 | WO2006111346A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators |
| 10/26/2006 | WO2006111261A1 Substituted 2-amin0alkylthi0-benzimidaz0les and use thereof for reducing blood sugar levels |
| 10/26/2006 | US20060241301 Urea derivatives and their use as tyrosinkinase inhibitors |
| 10/26/2006 | US20060241101 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 10/26/2006 | DE102005018191A1 Substituierte zyklische Harnstoff-Derivate und deren Verwendung zur Herstellung von Arzneimitteln Substituted cyclic urea derivatives and their use for the preparation of medicaments |
| 10/26/2006 | CA2605144A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators |
| 10/26/2006 | CA2604719A1 Substituted 2-amin0alkylthi0-benzimidaz0les and use thereof for reducing blood sugar levels |
| 10/25/2006 | EP1713780A2 Novel inhibitors of glutaminyl cyclase |
| 10/25/2006 | EP1713515A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 10/25/2006 | EP1187613B9 Amide substituted imidazoquinolines |
| 10/25/2006 | CN1852968A Reactions products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives |
| 10/25/2006 | CN1852905A N-substituted benzimidazolyl c-kit inhibitors |
| 10/25/2006 | CN1850779A Beta-element nitrogenous derivative, and its preparing method and use |
| 10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
| 10/24/2006 | US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents |
| 10/24/2006 | US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 10/24/2006 | US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms |
| 10/24/2006 | US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents |
| 10/24/2006 | US7125876 Substituted heterocyclic compounds |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/24/2006 | CA2237650C Benzamidoxime prodrugs as antipneumocystic agents |
| 10/24/2006 | CA2222517C Agents for use against parasitic protozoa |
| 10/19/2006 | WO2006110683A1 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors |
| 10/19/2006 | WO2006108640A1 Phenylacetamides suitable as protein kinase inhibitors |
| 10/19/2006 | WO2006108488A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 10/19/2006 | WO2006108224A1 Antiparasitic compounds |
| 10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |
| 10/19/2006 | DE102005061720B3 Preparing optically active omeprazole enantiomers, useful to treat stomach diseases, comprises oxidizing prochiral sulfide compound with oxidizing agent in presence of titanium complex catalyst and reacting the catalyst with chiral diols |
| 10/19/2006 | DE102005017605A1 Substiuierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substiuierte 2-aminoalkylthio-benzimidazoles, process for their preparation and their use as medicaments |
| 10/19/2006 | CA2603941A1 Phenylacetamides suitable as protein kinase inhibitors |
| 10/19/2006 | CA2602303A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 10/18/2006 | CN1849303A Novel heteroaryl derivative |
| 10/18/2006 | CN1847242A Novel process for producing ramosetron or its salt |
| 10/18/2006 | CN1280314C Method for controlling polymer molecular weight and structure |
| 10/18/2006 | CN1280267C Sulfonylaminocarboxylic acids |
| 10/18/2006 | CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 10/17/2006 | US7122567 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity |
| 10/17/2006 | US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer |
| 10/12/2006 | WO2006107035A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element |
| 10/12/2006 | WO2006106812A1 Propane-1,3-dion derivative or salt thereof |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106326A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/12/2006 | WO2006063578A3 Method for production of candesartan |
| 10/12/2006 | WO2006048750A3 Novel compounds of substituted and unsubstituted adamantyl amides |
| 10/12/2006 | CA2602467A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | CA2601983A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1709015A1 Organic compounds |
| 10/11/2006 | EP1709006A1 Benzimidazole derivatives |
| 10/11/2006 | EP1358309B1 Composition and method for bleaching a substrate |
| 10/11/2006 | CN1845905A PPAR-activating compound and pharmaceutical composition comprising the compound |
| 10/10/2006 | US7118760 esters with with C16 to C50 alcohols and/or siloxane derivatives; increased water resistance, increased stability, improved permanence |
| 10/10/2006 | CA2352554C Substituted benzimidazoles and their use as parp inhibitors |
| 10/10/2006 | CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 10/05/2006 | WO2006104349A1 Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006103068A1 A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 10/05/2006 | WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases |
| 10/05/2006 | WO2006058012A3 Gonadotropin releasing hormone receptor antagonists |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223868 Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1) |
| 10/05/2006 | CA2603589A1 Inhibitors of histone deacetylase |
| 10/04/2006 | EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative |
| 10/04/2006 | EP1706398A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 10/04/2006 | EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 10/04/2006 | EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115645 Central nervous system disorders; antiinflammatory agents |
| 10/03/2006 | US7115644 Antiinflammatory agents; osteoarthritic; antihistamines; multiple sclerosis; antiulcer agents; skin disorders; graft versus host disease; abtidiabetic agents; Alzheimer's disease; antidiabetic agents |
| 10/03/2006 | US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines |
| 10/03/2006 | CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 10/03/2006 | CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions |
| 10/03/2006 | CA2268840C Benzimidazole-2-carbamates for the treatment of viral infections and cancer |
| 09/28/2006 | WO2006100254A1 6-thioamide substituted benzimidazoles |
| 09/28/2006 | WO2006053342A3 Integrin antagonists useful as anticancer agents |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | CA2601381A1 6-thioamide substituted benzimidazoles |
| 09/27/2006 | EP1704145A1 Selective kinase inhibitors |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | CN1839127A Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 09/27/2006 | CN1837196A Process for synthesizing benzimidazole by microwave radiation |
| 09/26/2006 | US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 09/21/2006 | WO2006099379A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097766A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |